HT
DCPH

HAP Trading’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

HAP Trading’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-26,163
Closed -$1.56M – 1978
2020
Q2 		$1.56M Buy
+26,163
New +$1.4M 0.09% 207

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

HAP Trading's DCPH Position: Q3 2020 in Review

HAP Trading sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2020, closing a stake of 26,163 shares — an estimated $1.56M sold.

HAP Trading first reported a position in DCPH in Q2 2020 and held it in 1 quarter. The position peaked at $1.56M in Q2 2020. 161 funds tracked by Wall St. Rank hold DCPH as of Q3 2020.

  • HAP Trading reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • HAP Trading sold 26,163 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $1.56M.
  • HAP Trading first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • HAP Trading's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.56M in Q2 2020.
  • 161 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on HAP Trading's 13F filing for Q3 2020, filed 13 Nov 2020.